Join our team at DDF Berlin and learn more about user-centric and planet-centric design in drug delivery.
Author profile
エリザベス トーマス
バイオ医薬品事業開発者
製薬・バイオテクノロジー分野の医療技術に特化した英国を拠点とするグローバル医療技術部門のメンバー。生物学、ソフトウェア、エンジニアリングを組み合わせた革新的で技術的な製品およびプロセスの開発・市場投入のため、グローバル製薬企業および新興企業とのパートナーシップを構築した経験を持つ。ダラム大学で生物医学を専攻し、神経発達障害及び神経変性疾患の分野で経験を積む。
She has a background in Biomedical Sciences from Durham University, with experience in neurodevelopmental and neurodegenerative disorders.
My insights
Quantum computing for pharma and life sciences
What can quantum computing and quantum technology do for the pharma and life sciences industry? Elizabeth Thomas has conferred with Cambridge Consultants’ quantum experts and shares her insights into how organisations can start implementing an action plan.
Sustainability at the heart of drug delivery product design
Lizzie Thomas presents her case for designing improved, sustainable drug delivery product design. Currently, the approach is dominated at the outset by patient-centricity. This focus means that wider, more long-term implications simply aren’t considered early enough.